Cargando…
Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand?
Venous thromboembolism (VTE), comprising deep-vein thrombosis and pulmonary embolism, is a frequent complication in ambulatory cancer patients. Despite the high risk, routine thromboprophylaxis is not recommended because of the high number needed to treat and the risk of bleeding. Two recent trials...
Autores principales: | Mulder, Frits I., Bosch, Floris T. M., van Es, Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072463/ https://www.ncbi.nlm.nih.gov/pubmed/32033438 http://dx.doi.org/10.3390/cancers12020367 |
Ejemplares similares
-
ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011) -
Where Do We Stand?
Publicado: (1891) -
Maximizing neuroprotection: where do we stand?
por: Kuffler, Damien P
Publicado: (2012) -
Where do we stand with IPF treatment?
por: Albera, C, et al.
Publicado: (2013) -
Schistosomiasis vaccines: where do we stand?
por: Tebeje, Biniam Mathewos, et al.
Publicado: (2016)